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A 49-year-old man received prolotherapy in the upper cervical region at a local medical clinic. Immediately after 
the procedure, he felt a sensation resembling an electric shock in his right upper and lower extremities, and 
continuously complained of numbness and discomfort in the right hemibody. He visited our clinic a week later. 
Upon physical examination, there were no signifi  cant abnormal fi  ndings. Th   e visual analog scale was 60 points. 
T2-weight magnetic resonance images of the cervical spine showed a 0.7 cm sized bright oval spot on the right side 
of the spinal cord at the level of C4-C5 disc, suggesting spinal cord injury. Th   ere were no defi  nite electrodiagnostic 
abnormalities. Digital infrared thermal images showed moderately decreased surface temperature on lateral 
aspect of the right forearm and dorsum of the right hand compared with the other side. Considering that very rare 
complications like spinal cord injury may develop after prolotherapy, we suggest that special interventions such as 
prolotherapy be performed by professional experts.
Key Words Spinal cord injury, Complications, Malpractice
Annals of Rehabilitation Medicine
Case Report
Ann Rehabil Med 2011; 35: 570-573
pISSN: 2234-0645 • eISSN: 2234-0653
http://dx.doi.org/10.5535/arm.2011.35.4.570
INTRODUCTION
  Prolotherapy is a pain-relieving treatment. Th  e  mecha-
nism of action of prolotherapy is that the injection of 
proliferating agents onto the lax ligament or tendon 
triggers acute inflammatory reaction inducing the 
proliferation of fi  broblast and collagen growth.
1 Common 
side eff  ects regarding prolotherapy are pain and bleeding 
with an occasional sense of fullness and numbness. 
However, most of them are naturally healed. In addition, 
a pain fl  are during the fi  rst 72 hours after the injections 
is common clinically but its incidence has not been 
well documented. While prolotherapy performed by 
an experienced expert appears safe, the injection of 
ligaments, tendons and joints with irritant solutions 
raises safety concerns. Adverse events of prolotherapy 
injections include light-headedness, allergic reaction, 
infection or neurological damage with rare cases of 
severe complications.
2 This case study aims to report 
the unusual cases of cervical spinal cord injury as 
complication of prolotherapy.
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CASE REPORT
A 49 year-old man received prolotherapy after suffering 
from pains at the right shoulder and elbow for five 
months at a local medical clinic one week before his 
visit to our clinic. Diagnosed with tendinitis, the patient 
got both physiotherapy and prolotherapy using a mixed 
solution of 15% dextrose and 0.125% lidocain onto the 
near right C5 nerve root, right shoulder and elbow. 
Right after prolotherapy, he suffered from a sensation 
resembling an electrical shock on both upper and lower 
extremities and weakness. Since then, the numbness and 
pain on the right upper and lower extremities persisted, 
leading to visit our outpatient care. His medical history 
showed no hypertension, diabetes mellitus, tuberculosis 
and trauma and got an appendectomy over acute 
appendicitis about 15 years ago. He complained of 
intermittent numbness and discomfort over the right 
upper and lower extremities. Though the pain was 
aggravated due to weather condition, there was no 
particular relieving factor. Th   e visual analogue scale (VAS) 
checked 60 points. Neurological examination showed his 
consciousness was on alert mental state. Manual muscle 
test showed all extremities were normal and the sensory 
examination showed no indication of hypoesthesia 
despite the fact that he complained of numbness on the 
sensory dermatome at the level of C5-C7 nerve root. 
Vibration and proprioception tests showed no signs of 
abnormality. Perianal sense and anal sphincter’s tones 
were well kept and a bulbocavernosus reflex was not 
unusual. His case was classified as American Spinal 
Injury Association (ASIA) impairment scale E level. 
Deep tendon refl  ex was within the normal range without 
spasticity and the ability to carry out activities of daily 
living and gait functioned independently. Laboratory 
test and cervical spine X-ray identified no sign of 
abnormality. A digital infrared thermal imaging study 
showed lateral aspect of right and dorsum of hand had 
Fig. 1. Digital infrared thermal images 
show moderately decreased surface 
temperature on lateral aspect of right 
forearm and dorsum of right hand 
(arrow) compared with the other 
side. (A) anterior view; (B) posterior 
view.
Fig. 2. Magnetic resonance images 
of the cervical spine: T2-weighted 
sagittal image (A) and T2-weighted 
axial image (B) show 0.7 cm sized 
bright oval spot (arrow) on the right 
side of the spinal cord at the level of 
the C4-C5 disc.Hyun-Sik Yun, et al.
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a lower skin temperature compared with the left side by 
0.6-0.8
oC (Fig. 1). 
  Somatosensory evoked potential and magnetic 
motor evoked potential studies found no definite 
electrodiagnostic abnormalities and T2-weighted 
magnetic resonance images (MRI) of cervical spine 
showed about 0.7 cm sized oval spot with high signal 
intensity on the right side of the spinal cord at the level of 
C4-C5 disc. Other mass or signal changes from arachnoid 
membrane were not observed (Fig. 2). For neuropathic 
pain relief, the patient used oral administration of 
Gabapentin 100 mg once a day for two weeks. As part 
of physiotherapy, transcutaneous electrical nerve 
stimulation (20 Hz, 10-50 mA, 10 minutes) and infrared 
therapy (60 Hz, 770 nm, 250 W, 10 minutes) were con-
ducted once a day for two weeks. Additionally, stretching 
exercise at neck and upper extremities along with 
strengthening exercises such as isometric fl  exion exercise 
and extension exercise of cervical paraspinalis muscles 
were carried out. After one month of outpatient sessions, 
his pain level was reduced from 60 to 20 points at VAS.
DISCUSSION
  There are a variety of therapeutic options available 
to reduce chronic musculoskeletal pain. However, 
patients often rely on complementary and alternative 
medical (CAM) therapy such as acupuncture or club 
needle. Prolotherapy is a type of CAM therapy injecting 
proliferative solution to reduce chronic musculoskeletal 
pain.
2 Still, without sufficient understanding and 
knowledge of safety over a particular type of CAM 
therapy, its benefits may be cancelled out. In addition, 
invasive CAM therapy is highly likely to cause side eff  ects 
and adverse events.
3
  The question over the safety of prolotherapy naturally 
led to a study regarding its side effects and adverse 
events. In a study of prolotherapy-induced side effects 
and adverse events on the  neck and back in the North 
America, Dagenais et al.
3 reported that the side effect 
with the highest estimated median prevalence was pain 
(70%), followed by stiffness (25%), bruising (5%), and 
temporary numbness (1%). On the other hand, the most 
commonly reported adverse events were cases of spinal 
headache, pneumothorax, temporary systemic reactions 
and nerve damage with rare cases of spinal cord insult 
such as meningitis, paralysis and spinal cord injury. 
  The previous study reported few severe complications 
such as neurological impairment resulting from spinal 
cord irritation. The mechanism behind these severe 
complications is that after prolotherapy on spinal 
aspects, proliferating solution was injected into sub-
arachnoid space, causing pain and paraplegia, and 
adhesive arachnoiditis progressed chronically into 
mental deepening, hydrocephalus and other fatal 
complications.
4-6 Out of a slew of adverse events, 
intervertebral damage, nerve injury, spinal cord injury 
and hemorrhage can take place because of improper 
injection technique.
3 Th   is case study also suggested that 
improper injection techniques were the reason behind a 
rare complication of cervical spinal cord injury. 
  In the case of adverse events such as spinal headache and 
pneumothorax, most are easily dealt with no permanent 
sequelae.
1,3 In this study, MRI findings identified spinal 
cord injury but there were few neurological symptoms 
except pain and after conservative physiotherapy and 
medication, the pain was reduced to a tolerable level. 
Nevertheless, given that some patients can suffer from 
delayed neurological impairment, though not right 
after injection, even though patients show signs of 
improvement, additional observation should be required 
to prevent neurological impairment.
4-6
  These side effects and adverse effects are similarly 
reported on other injection methods commonly used in 
the spine such as facet joint block, epidural block and 
local injection.
7-10 Also, complications from invasive 
injection modality can occur irrespective of the drug 
being injected.
3 Many of the detailed adverse event 
analyses indicate that needle injuries occurred when 
probing for the desired injection site with the needle 
tip, before delivering the intended bolus of the drug. 
Although we are aware that fluoroscopy is occasionally 
used for needle guidance by certain prolotherapy 
practitioners, this equipment was not widely available 
to many practitioners. Moreover, there is currently 
no evidence that this procedure leads to fewer needle 
injuries.
3 However, given that needle injury is more likely 
to cause complications than the drug itself, it is desirable 
to use the fl  uoroscope or improve the injection technique 
of physician.
  In the field of pain rehabilitation medicine, diverse 
invasive procedures are conducted for the purpose of Prolotherapy-induced Cervical Spinal Cord Injury   
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diagnosis and therapy. However, procedures conducted 
unsuitably and by inexperienced physician can invite 
many side eff  ects and complications. To prevent this, the 
understanding of anatomical structure on injection site is 
required and the procedure should be carried out under 
the guidance of a skilled expert or by physician with 
adequate training.
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